Xogene at PHUSE US Connect 2027: Advancing AI & Transparency
Insights
AWS Case Study: Cutting results-posting time 94% with Transcend
AWS case study on Xogene's Transcend: results-posting time cut 94% with agentic AI on Amazon Bedrock...
Highlights from the Xogene US Summit 2026
Disclosure and transparency leaders from biopharma sponsors met in New York for two days on AI in pr...
Xogene Named Finalist for Best Bespoke or Specialized AI Solution in The 2026 A.I. Awards
Xogene's Transcend advances to the finalist stage of a global AI awards program.
Product Updates
Prime 4.0.1: Expanding Registry Coverage
Prime 4.0.1 adds support for 17 new country registries and a set of updates to how forms and disclosure data are managed across registries, making it easier to keep data consistent as coverage grows.
Xogene Launches Prime 4.0
Built for How You Disclose — Configure Your Plan, Coordinate Work, and Control Every Disclosure
Transcend: Accelerating Transparency with AI
Purpose-built platform combines 16 years of domain expertise with agentic AI to deliver 80% time savings for transparency activities.
Xogene Launches Prime 3.4.1
Xogene launched the latest iteration of Prime, the leading end-to-end platform that provides unified oversight, automated workflows, and effortless compliance for clinical trial transparency.
Regulatory Updates
Regulatory updates: ClinicalTrials.gov, CCMO, and HRA
ClinicalTrials.gov updates the Modernized PRS, CCMO updates protocol templates ahead of the 2027 IVO...
EMA Pilot Program & Holiday Schedules
Two regulatory updates this week that clinical trial teams should be aware of: an EMA pilot program ...
Updates from Clinical Trial Highlight Issue 28
This week's regulatory updates include enhancements to the HMA-EMA RWD Catalogues and key developmen...
.png)
